No Data
Express News | Processa Pharmaceuticals Inc - Grants Intact Therapeutics Exclusive Option to License Pcs12852
Express News | Processa Pharmaceuticals Inc - Terminates Licensing Agreement With Ocuphire Pharma - SEC Filing
Express News | Processa Pharmaceuticals Inc - Continue Enrolling Patients in Phase 2 Study of Pcs6422
Processa Pharmaceuticals Provides Portfolio and Business Update
Processa Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Processa Pharmaceuticals Analyst Ratings